Stipan Jonjić

Active 1984–2025

93
Papers
18,439
Citations
63
h-index
91
i10-index

Citations

Citations per year for Stipan Jonjić1952: 1 citations1986: 3 citations1987: 6 citations1988: 24 citations1989: 37 citations1990: 33 citations1991: 28 citations1992: 18 citations1993: 30 citations1994: 47 citations1995: 41 citations1996: 27 citations1997: 37 citations1998: 95 citations1999: 87 citations2000: 68 citations2001: 72 citations2002: 93 citations2003: 98 citations2004: 106 citations2005: 124 citations2006: 114 citations2007: 93 citations2008: 166 citations2009: 136 citations2010: 183 citations2011: 167 citations2012: 213 citations2013: 234 citations2014: 245 citations2015: 313 citations2016: 89 citations2017: 137 citations2018: 152 citations2019: 539 citations2020: 505 citations2021: 545 citations2022: 419 citations2023: 345 citations2024: 522 citations2025: 242 citations2026: 9 citations1953–1985: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,123 citing papers, 27.3% of this breakdownChina: 890 citing papers, 11.4% of this breakdownGermany: 652 citing papers, 8.4% of this breakdownUnited Kingdom: 502 citing papers, 6.4% of this breakdownItaly: 351 citing papers, 4.5% of this breakdownFrance: 291 citing papers, 3.7% of this breakdownAustralia: 241 citing papers, 3.1% of this breakdownCanada: 225 citing papers, 2.9% of this breakdownJapan: 217 citing papers, 2.8% of this breakdownNetherlands: 177 citing papers, 2.3% of this breakdownSwitzerland: 174 citing papers, 2.2% of this breakdownSpain: 144 citing papers, 1.8% of this breakdown
0%27.3%Other 23.2%

Fields

  • Medicine35.4%
  • Immunology and Microbiology28.6%
  • Biochemistry, Genetics and Molecular Biology20.4%
  • Neuroscience2.9%
  • Agricultural and Biological Sciences2.1%
  • Computer Science1.8%
  • Other8.8%

Topics

  • Immune Cell Function and Interaction10%
  • T-cell and B-cell Immunology5.2%
  • Cytomegalovirus and herpesvirus research4.9%
  • Gut microbiota and health3.6%
  • Cancer Immunotherapy and Biomarkers3.4%
  • Immunotherapy and Immune Responses3%
  • Other69.9%

Coauthors

All papers

Open in search
  1. Binding of the Fap2 Protein of Fusobacterium nucleatum to Human Inhibitory Receptor TIGIT Protects Tumors from Immune Cell Attack

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Immunity 2015 cited by 1,429

  2. The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity

    Authors: , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2009 cited by 3,538

  3. NKp46 Receptor-Mediated Interferon-γ Production by Natural Killer Cells Increases Fibronectin 1 to Alter Tumor Architecture and Control Metastasis

    Authors: , , , , , , , , , , , , , , - Immunity 2018 cited by 216

  4. Virus-Induced Interferon-γ Causes Insulin Resistance in Skeletal Muscle and Derails Glycemic Control in Obesity

    Authors: , , , , , , , , , , - Immunity 2018 cited by 188

  5. Nectin4 is a novel TIGIT ligand which combines checkpoint inhibition and tumor specificity

    Authors: , , , , , , , , , , , , - Journal for ImmunoTherapy of Cancer 2020 cited by 123

  6. TIGIT can inhibit T cell activation via ligation-induced nanoclusters, independent of CD226 co-stimulation

    Authors: , , , , , , , , , , , , , , , , , - Nature Communications 2023 cited by 55

  7. Targeting PVR (CD155) and its receptors in anti-tumor therapy

    Authors: , , , , , - Cellular and Molecular Immunology 2018 cited by 169

  8. Guidelines for the use of flow cytometry and cell sorting in immunological studies *

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ana Cumano, Van Duc Dang, Derek Davies, Sara De Biasi, Genny Del Zotto, Silvia Della Bella, Paolo Dellabona, Günnur Deniz, Mark C. Dessing, Andreas Diefenbach, James P. Di Santo, Francesco Dieli, Andreas Dolf, Vera S. Donnenberg, Thomas Dörner, Götz R. A. Ehrhardt, Elmar Endl, Pablo Engel, Britta Engelhardt, Charlotte Esser, Bart Everts, Anita Dreher, Christine S. Falk, Todd A. Fehniger, Andrew Filby, Simon Fillatreau, Marie Follo, Irmgard Förster, John R. Foster, Gemma A. Foulds, Paul S. Frenette, David W. Galbraith, Natalio Garbi, Maria Dolores García‐Godoy, Jens Geginat, Kamran Ghoreschi, Lara Gibellini, Christoph Goettlinger, Carl S. Goodyear, Andrea Gori, Jane L. Grogan, Mor Gross, Andreas Grützkau, Daryl Grummitt, Jonas Hahn, Quirin Hammer, Anja E. Hauser, David L. Haviland, David W. Hedley, Guadalupe Herrera, Martin Herrmann, Falk Hiepe, Tristan Holland, Pleun Hombrink, Jessica P. Houston, Bimba F. Hoyer, Bo Huang, Christopher A. Hunter, Anna Iannone, Hans‐Martin Jäck, Beatriz Jávega, Stipan Jonjić, Kerstin Juelke, Steffen Jung, Toralf Kaiser, Tomáš Kalina, Baerbel Keller, Srijit Khan, Deborah Kienhöfer, Thomas Kroneis and 136 more - European Journal of Immunology 2017 cited by 552

  9. Mouse TIGIT inhibits NK‐cell cytotoxicity upon interaction with PVR

    Authors: , , , , , , , , - European Journal of Immunology 2013 cited by 249

  10. Modulation of innate and adaptive immunity by cytomegaloviruses

    Authors: , , , , - Nature reviews. Immunology 2019 cited by 118

  11. Cytomegalovirus Infection and Inflammation in Developing Brain

    Authors: , , , - Viruses 2021 cited by 78

  12. Degradation of Cellular miR-27 by a Novel, Highly Abundant Viral Transcript Is Important for Efficient Virus Replication In Vivo

    Authors: , , , , , , , , , , , , , , , , - PLoS Pathogens 2012 cited by 208

  13. ChAdOx1‐S adenoviral vector vaccine applied intranasally elicits superior mucosal immunity compared to the intramuscular route of vaccination

    Authors: , , , , , , , , , , , , , , , , , , , - European Journal of Immunology 2022 cited by 33

  14. IL-1R8 is a checkpoint in NK cells regulating anti-tumour and anti-viral activity

    Authors: , , , , , , , , , , , , , , - Nature 2017 cited by 235

  15. Murine CMV-Induced Hearing Loss Is Associated with Inner Ear Inflammation and Loss of Spiral Ganglia Neurons

    Authors: , , , , , - PLoS Pathogens 2015 cited by 93

  16. Cytomegalovirus inhibition of extrinsic apoptosis determines fitness and resistance to cytotoxic CD8 T cells

    Authors: , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2020 cited by 37

  17. Type I Interferons Protect T Cells against NK Cell Attack Mediated by the Activating Receptor NCR1

    Authors: , , , , , , , , , - Immunity 2014 cited by 225

  18. Virus Progeny of Murine Cytomegalovirus Bacterial Artificial Chromosome pSM3fr Show Reduced Growth in Salivary Glands due to a Fixed Mutation of MCK-2

    Authors: , , , , , , - Journal of Virology 2011 cited by 154

  19. Site-restricted persistent cytomegalovirus infection after selective long-term depletion of CD4+ T lymphocytes.

    Authors: , , , , - The Journal of Experimental Medicine 1989 cited by 2,108

  20. Gain of Virulence Caused by Loss of a Gene in Murine Cytomegalovirus

    Authors: , , , , , , , - Journal of Virology 2004 cited by 561

  21. Mouse Hobit is a homolog of the transcriptional repressor Blimp-1 that regulates NKT cell effector differentiation

    Authors: , , , , , , , - Nature Immunology 2012 cited by 84

  22. NK/ILC1 cells mediate neuroinflammation and brain pathology following congenital CMV infection

    Authors: , , , , , , , , , , , , , , - The Journal of Experimental Medicine 2021 cited by 59

  23. Virus-induced cochlear inflammation in newborn mice alters auditory function

    Authors: , , , , , - JCI Insight 2019 cited by 47

  24. Amplification of autoimmune organ damage by NKp46-activated ILC1s

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kevin Thurley, Andreas Schlitzer, Christoph Schneider, Efstathios G. Stamatiades, Mir‐Farzin Mashreghi, Stipan Jonjić, Norbert Hübner, Andreas Diefenbach, Masatoshi Kanda, Antigoni Triantafyllopoulou - Nature 2024 cited by 29